Key players operating in the smart home healthcare are Celgene Corporation,
Mesoblast Ltd., Pluristem Therapeutics Inc., MEDIPOST Co., Ltd., Takeda
Pharmaceutical Company Limited, Astellas Pharma Inc., Cellular Biomedicine
Group, Inc., Biosolution Co., Ltd., StemCell Technologies Inc., Caladrius
Biosciences, Inc., TiGenix N.V., ViaCord, Vericel Corporation, Regen Biopharma
Inc., Gamida Cell Ltd., Histogenics Corporation, BrainStorm Cell Therapeutics
Inc., Lineage Cell Therapeutics, Inc. The growing geriatric population is
increasing the demand for remote healthcare and assisted living solutions globally.
Advancements in IoT, AI, and sensor technology are enabling innovative smart
home healthcare devices with augmented diagnostic and therapeutic capabilities.
Market trends:
The growing focus on independent living is a key trend expected to accelerate
adoption of smart home healthcare solutions. Chronic disease management at home
offers better outcomes compared to facility-based care. Additionally,
consumerization and introduction of AI assistants for healthcare tasks will be
a defining trend over the next decade. The market is also expected to witness
growing emphasis on data analytics and predictive capabilities enabled by
integration of medical records with smart home platforms.
Market Opportunities:
Emerging markets such as Asia Pacific and Middle East present significant
opportunities for smart home healthcare providers owing to growing healthcare
infrastructure and increasing acceptability of remote patient monitoring.
Furthermore, development of innovative solutions leveraging technologies such as
AR/VR and blockchain for applications such as virtual therapy and decentralized
clinical trials could open new growth frontiers in the market.
Impact of COVID-19 on Smart Home Healthcare Market Growth
The COVID-19 pandemic has significantly impacted the growth of the
Smart
Home Healthcare Market Size . lockdowns imposed due to the outbreak
have increased the demand for remote health monitoring devices and services
which can help monitor patients from home. This has propelled the adoption of
various smart home healthcare devices like activity monitors, vital sign
monitoring devices, medication dispensers, and video consultation devices.
Telehealth platforms providing virtual consultation have witnessed exponential
growth during this period. Home healthcare agencies are actively promoting the
use of smart home solutions to remotely monitor patients with coronavirus or
other chronic conditions from their homes in order to reduce hospital visits.
However, supply chain disruptions caused due to lockdowns have temporarily
affected the production and supply of smart home healthcare devices in the
initial months of the pandemic. With restrictions being gradually lifted,
production levels are returning to normal. Going forward, the demand for smart
home healthcare is expected to remain high even post pandemic as remote patient
monitoring is seen as a sustainable healthcare model. Health systems are also
accelerating their digitalization initiatives to strengthen telehealth
infrastructure on a long-term basis.
In terms of geographical concentration, North America currently dominates the
global smart home healthcare market in terms of value, accounting for the
largest share. This is attributed to factors such as rising healthcare costs,
high penetration of smart home technologies, increasing prevalence of chronic
conditions and rapid adoption of remote monitoring solutions among the elderly
population in the region. Europe and Asia Pacific are also regarded as
lucrative markets poised to exhibit significant growth during the forecast
period.
The fastest growing regional market for smart home healthcare is anticipated to
be Asia Pacific over the next few years. This growth can be attributed to
elements such as rising geriatric population, increasing healthcare expenditure,
growing incidence of lifestyle diseases, entry of global players and
improvements in digital health infrastructure across countries like China,
India, Japan and Australia.
Comments
Post a Comment